Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10662/22337
Registro completo de Metadatos
Campo DCValoridioma
dc.contributor.authorFernández Rebollo, Eduardo-
dc.contributor.authorLecumberri Santamaría, Beatriz-
dc.contributor.authorGarin Elkoro, Intza-
dc.contributor.authorArroyo Díez, Francisco Javier-
dc.contributor.authorBernal Chico, Ana-
dc.contributor.authorGoñi Goicoechea, Fernando-
dc.contributor.authorOrduña Espinosa, Rosa-
dc.contributor.authorSpanish PHP Group-
dc.contributor.authorCastaño González, Luis-
dc.contributor.authorPérez de Nanclares Leal, Guiomar-
dc.date.accessioned2024-09-19T14:35:02Z-
dc.date.available2024-09-19T14:35:02Z-
dc.date.issued2010-
dc.identifier.issn0804-4643-
dc.identifier.urihttp://hdl.handle.net/10662/22337-
dc.descriptionPublicado en: European Journal of Endocrinology, Volume 163, Issue 6, Dec 2010, Pages 953–962, https://doi.org/10.1530/EJE-10-0435es_ES
dc.description.abstractPURPOSE: Type I pseudohypoparathyroidism (PHP-I) can be subclassified into Ia and Ib, depending on the presence or absence of Albright's hereditary osteodystrophy's phenotype, diminished α-subunit of the stimulatory G protein (Gsα) activity and multihormonal resistance. Whereas PHP-Ia is mainly associated with heterozygous inactivating mutations in Gsα-coding exons of GNAS, PHP-Ib is caused by imprinting defects of GNAS. To date, just one patient with PHP and complete paternal uniparental disomy (UPD) has been described. We sought to identify the underlining molecular defect in twenty patients with parathyroid hormone resistance, hypocalcemia and hyperphosphatemia, and abnormal methylation pattern at GNAS locus. METHODS: Microsatellite typing and comparative genome hybridization were performed for proband and parents. RESULTS: We describe four patients with partial paternal UPD of chromosome 20 involving pat20qUPD in one case, from 20q13.13-qter in two cases, and pat20p heterodisomy plus interstitial 20q isodisomy in one patient. CONCLUSIONS: These observations demonstrate that mitotic recombination of chromosome 20 can also give rise to UPD and PHP, a situation similar to other imprinting disorders, such as Beckwith–Wiedemann syndrome or neonatal diabetes.es_ES
dc.description.sponsorshipG Pérez de Nanclares is co-funded by the Instituto de Salud Carlos III I3SNS Program (CP03/0064; SIVI 1395/09). I Garin has received a grant from the Basque Department of Education (BFI06.266). This work was partially funded by grant GV2008/111035 from the Basque Department of Health and BIO08/ER/001. This group is also supported by the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER – the Spanish Biomedical Network Research Centre on Rare Diseases), ISCIII.es_ES
dc.format.extent11 p.es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPseudohipoparatiroidismo tipo Ies_ES
dc.subjectType I pseudohypoparathyroidismes_ES
dc.subjectDisomía paterna uniparentales_ES
dc.subjectPaternal uniparental disomyes_ES
dc.subjectHormona paratiroideaes_ES
dc.subjectParathyroid hormonees_ES
dc.subjectHipocalcemiaes_ES
dc.subjectHypocalcemiaes_ES
dc.subjectHiperfosfatemiaes_ES
dc.subjectHyperphosphatemiaes_ES
dc.subjectEstudio clínicoes_ES
dc.subjectClinical studyes_ES
dc.titleNew mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidismes_ES
dc.typearticlees_ES
dc.description.versionpeerReviewedes_ES
europeana.typeTEXTen_US
dc.rights.accessRightsopenAccesses_ES
dc.subject.unesco3205.02 Endocrinologíaes_ES
europeana.dataProviderUniversidad de Extremadura. Españaes_ES
dc.identifier.bibliographicCitationEduardo Fernández-Rebollo, Beatriz Lecumberri, Intza Garin, Javier Arroyo, Ana Bernal-Chico, Fernando Goñi, Rosa Orduña, Spanish PHP Group, Luis Castaño, Guiomar Pérez de Nanclares, New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism, European Journal of Endocrinology, Volume 163, Issue 6, Dec 2010, Pages 953–962, https://doi.org/10.1530/EJE-10-0435es_ES
dc.type.versionacceptedVersiones_ES
dc.contributor.affiliationHospital Universitario de Cruces. Vizcayaes_ES
dc.contributor.affiliationUniversidad de Extremadura. Departamento de Ciencias Biomédicases_ES
dc.contributor.affiliationHospital Universitario La Paz. Madrides_ES
dc.contributor.affiliationComplejo Hospitalario Universitario de Cácereses_ES
dc.contributor.affiliationHospital de Basurto. Bilbaoes_ES
dc.contributor.affiliationHospital Universitario San Cecilio. Granadaes_ES
dc.contributor.affiliationUniversidad del País Vascoes_ES
dc.relation.publisherversionhttps://academic.oup.com/ejendo/article-abstract/163/6/953/6676625?redirectedFrom=fulltext&login=truees_ES
dc.identifier.doi10.1530/EJE-10-0435-
dc.identifier.publicationtitleEuropean Journal of Endocrinologyes_ES
dc.identifier.publicationfirstpage1es_ES
dc.identifier.publicationlastpage11es_ES
dc.identifier.publicationvolume163es_ES
dc.identifier.e-issn1479-683X-
dc.identifier.orcid0000-0002-6323-634Xes_ES
Colección:DCBIO - Artículos

Archivos
Archivo Descripción TamañoFormato 
EJE-10-0435_AAM.pdf288,37 kBAdobe PDFDescargar


Este elemento está sujeto a una licencia Licencia Creative Commons Creative Commons